Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,078 | 15 | 54.5% |
| Consulting Fee | $900.00 | 1 | 45.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $1,543 | 6 | $0 (2024) |
| Inspire Medical Systems, Inc. | $278.35 | 1 | $0 (2022) |
| Resmed Corp | $90.41 | 4 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $35.57 | 2 | $0 (2021) |
| Itamar Medical Inc | $19.87 | 2 | $0 (2024) |
| Davol Inc. | $10.82 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $193.34 | 4 | JAZZ PHARMACEUTICALS INC. ($154.86) |
| 2023 | $183.80 | 2 | JAZZ PHARMACEUTICALS INC. ($142.78) |
| 2022 | $518.10 | 3 | Inspire Medical Systems, Inc. ($278.35) |
| 2021 | $20.31 | 1 | Merck Sharp & Dohme Corporation ($20.31) |
| 2020 | $915.26 | 2 | Jazz Pharmaceuticals Inc. ($900.00) |
| 2019 | $136.11 | 3 | JAZZ PHARMACEUTICALS INC. ($105.33) |
| 2017 | $10.82 | 1 | Davol Inc. ($10.82) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Resmed Corp | AIRSENSE (Device) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: Sleep | ||||||
| 09/05/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| Category: Sleep Apnea testing | ||||||
| 06/10/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $5.59 | General |
| Category: Sleep Apnea testing | ||||||
| 06/02/2024 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $154.86 | General |
| 11/07/2023 | Resmed Corp | AIRSENSE (Device) | Food and Beverage | Cash or cash equivalent | $41.02 | General |
| Category: Sleep | ||||||
| 06/05/2023 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | In-kind items and services | $142.78 | General |
| 12/08/2022 | Inspire Medical Systems, Inc. | Inspire Upper Airway Stimulation System (Device) | Food and Beverage | Cash or cash equivalent | $278.35 | General |
| Category: Neurology | ||||||
| 06/07/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $99.50 | General |
| Category: NEUROLOGY | ||||||
| 06/05/2022 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug), SUNOSI, XYWAV | Food and Beverage | In-kind items and services | $140.25 | General |
| Category: NEUROLOGY | ||||||
| 02/01/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2020 | Jazz Pharmaceuticals Inc. | SUNOSI (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: NEUROLOGY | ||||||
| 09/14/2020 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2019 | Resmed Corp | AirSense (Device) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Sleep | ||||||
| 10/29/2019 | JAZZ PHARMACEUTICALS INC. | — | Food and Beverage | Cash or cash equivalent | $105.33 | General |
| 04/01/2019 | Resmed Corp | AirSense (Device) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Sleep | ||||||
| 11/15/2017 | Davol Inc. | DAV-Arista AH (Device) | Food and Beverage | Cash or cash equivalent | $10.82 | General |
| Category: Surgical | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 370 | 500 | $117,555 | $38,306 |
| 2022 | 4 | 301 | 453 | $92,385 | $34,005 |
| 2021 | 6 | 297 | 395 | $90,851 | $34,218 |
| 2020 | 7 | 271 | 328 | $81,998 | $22,923 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 163 | 214 | $60,776 | $22,446 | 36.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 50 | 51 | $20,808 | $7,054 | 33.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 86 | 159 | $7,858 | $3,691 | 47.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 18 | 21 | $10,370 | $1,950 | 18.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 19 | 20 | $10,992 | $1,916 | 17.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 12 | 13 | $1,472 | $676.78 | 46.0% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Facility | 2023 | 22 | 22 | $5,280 | $572.94 | 10.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 157 | 217 | $61,628 | $23,030 | 37.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 40 | 40 | $16,320 | $4,994 | 30.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 83 | 174 | $8,599 | $4,250 | 49.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 21 | 22 | $5,838 | $1,730 | 29.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 148 | 204 | $57,936 | $21,498 | 37.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 29 | 29 | $11,832 | $4,081 | 34.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 52 | 92 | $4,547 | $2,382 | 52.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 28 | 30 | $6,360 | $2,275 | 35.8% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 22 | 22 | $5,478 | $2,154 | 39.3% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2021 | 18 | 18 | $4,698 | $1,828 | 38.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 79 | 113 | $32,092 | $9,048 | 28.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 107 | 128 | $27,136 | $7,134 | 26.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 21 | 21 | $6,867 | $1,589 | 23.1% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2020 | 15 | 16 | $3,984 | $1,580 | 39.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 13 | 13 | $5,304 | $1,555 | 29.3% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2020 | 11 | 11 | $2,871 | $1,066 | 37.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 25 | 26 | $3,744 | $951.59 | 25.4% |
About Dr. Beth Ward, MD
Dr. Beth Ward, MD is a Neurology healthcare provider based in Chesterfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114945839.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beth Ward, MD has received a total of $1,978 in payments from pharmaceutical and medical device companies, with $193.34 received in 2024. These payments were reported across 16 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($1,078).
As a Medicare-enrolled provider, Ward has provided services to 1,239 Medicare beneficiaries, totaling 1,676 services with total Medicare billing of $129,453. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Sleep Medicine
- Location Chesterfield, MO
- Active Since 07/18/2006
- Last Updated 02/06/2014
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1114945839
Products in Payments
- SUNOSI (Drug) $900.00
- Inspire Upper Airway Stimulation System (Device) $278.35
- XYREM (Drug) $140.25
- XYWAV (Drug) $99.50
- AIRSENSE (Device) $59.63
- BELSOMRA (Drug) $35.57
- AirSense (Device) $30.78
- WatchPATONE (Device) $19.87
- DAV-Arista AH (Device) $10.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Chesterfield
Dr. William Rosenfeld, M.d, M.D
Neurology — Payments: $2.2M
Max Benzaquen, Md, MD
Neurology — Payments: $143,853
Dr. Emily Evans, Md, MD
Neurology — Payments: $86,320
Amy Rauchway, D.o, D.O
Neurology — Payments: $33,607
Zaheer Ahmed, M.d, M.D
Neurology — Payments: $21,742
Leah Brancheck, M.d, M.D
Neurology — Payments: $11,143